CONCLUSIONS We observed an increasing trend in intravenous immunoglobulin use and second-line treatment, no change in corticosteroid use, and a decreasing trend in no-treatment approaches, using a national inpatient database.
← all excerpts
Trends of Treatments for Pediatric Patients with Immune Thrombocytopenia in Japan.
1
—
—